APEIRON Expands Executive Board and Appoints Dr. Anderson Gaweco as Chief Medical and Scientific Officer (CMSO)

Dr. Gaweco will lead APEIRON’s rapidly advancing immuno-oncology programs and oversee the discovery, clinical and medical functions of the Company’s growing new molecular entities pipeline of innovative cancer immunotherapies.

 Press release

 Presseaussendung